ARTICLE | Clinical News
Fortamet metformin regulatory update
May 3, 2004 7:00 AM UTC
FDA granted marketing approval for Fortamet extended-release metformin tablets in 500 mg and 1000 mg strengths to lower blood glucose in Type II diabetes patients. The compound uses ADRX's Scot drug d...